Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06294314 · ClinicalTrials.gov registry record

Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace

A clinical trial of Anterior Cruciate Ligament Rupture, sponsored by Marshall University.

Recruiting
Registry status
450
Enrollment target
1
Study location

NCT06294314: Recruiting study of Anterior Cruciate Ligament Rupture, sponsored by Marshall University.

NCT06294314 is a study of Anterior Cruciate Ligament Rupture that is actively recruiting participants, run by Marshall University. The registered enrollment target is 450 participants, above the 98-participant average among 9 other Anterior Cruciate Ligament Rupture trials with a reported enrollment target (359% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06294314, a study of Anterior Cruciate Ligament Rupture, is actively recruiting participants, sponsored by Marshall University.

RECRUITING
Registry status
450 participants
Enrollment target
1
Study location

Study Summary

The Investigators are studying the effect of an ACL reconstruction on return to play by capturing outcome measures and biomechanics information.

Primary Outcome

Patient will be monitored for return to play at their sport

Interventions

  • PROCEDURE Fertilized ACL

Study Locations (1)

West Virginia

  • Marshall University - Huntington

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2024-02-26
Est. Completion 2028-07-01
Marshall University

12 total trials

What NCT06294314 shows while recruiting

NCT06294314 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, above the 98-participant average among 9 other Anterior Cruciate Ligament Rupture trials with a reported enrollment target (359% higher).

The record links to 1 condition, with Anterior Cruciate Ligament Rupture appearing as the primary indexed condition, and to 1 intervention - of which Fertilized ACL is the first listed.

NCT06294314 reports a single indexed study location in West Virginia.

Frequently Asked Questions

What is clinical trial NCT06294314 about?

NCT06294314 is a clinical study titled "Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace". The Investigators are studying the effect of an ACL reconstruction on return to play by capturing outcome measures and biomechanics information.

What is the current status of trial NCT06294314?

This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2024-02-26. Estimated completion is 2028-07-01.

What conditions does trial NCT06294314 study?

This clinical trial studies the following conditions: Anterior Cruciate Ligament Rupture.

What interventions are being tested in trial NCT06294314?

The interventions under investigation include: Fertilized ACL (PROCEDURE).

Who is sponsoring clinical trial NCT06294314?

This trial is sponsored by Marshall University, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06294314 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anterior Cruciate Ligament Rupture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06294314's enrollment target sits among peer trials

450 1st of 9 higher than 9 of 9 other Anterior Cruciate Ligament Rupture trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Rupture trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

  • NCT01257269 · 450 participants

    Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

  • NCT03047161 · 450 participants

    Electrophysiology of Fetal Arrhythmia

  • NCT03269630 · 450 participants

    New Orleans Pulmonary Hypertension Biobank

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06294314, the US trial registry maintained by the National Library of Medicine. NCT06294314 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.